 |
市場調査レポート
商品コード
1463326
オリゴヌクレオチド合成の世界市場規模、シェア、成長分析、最終用途別- 産業別予測、2024年～2031年Global Oligonucleotide Synthesis Market Size, Share, Growth Analysis, By End-use(Academic Research Institutes, Diagnostic Laboratories), By Application(PCR Primers, PCR Assays and Panels) - Industry Forecast 2024-2031 |
||||||
| オリゴヌクレオチド合成の世界市場規模、シェア、成長分析、最終用途別- 産業別予測、2024年～2031年 |
|
出版日: 2024年04月07日
発行: SkyQuest
ページ情報: 英文 219 Pages
納期: 3～5営業日
|
- 全表示
- 概要
- 目次
世界のオリゴヌクレオチド合成市場規模は、2022年に46億米ドルと評価され、予測期間（2024年～2031年）のCAGRは12.10%で、2023年の51億6,000万米ドルから2031年には128億6,000万米ドルに成長する見通しです。
オリゴヌクレオチド合成市場は、遺伝子合成、PCR、DNAシーケンシング、診断、治療など様々な目的のためにカスタマイズされたオリゴヌクレオチドや製造済みオリゴヌクレオチドを提供することで、研究者、科学者、メーカーのニーズに応えています。この市場の主な促進要因は、遺伝子研究の進歩に後押しされた合成生物学と個別化医療に対する需要の高まりです。さらに、がんや遺伝性疾患の罹患率の増加が市場の成長に寄与しています。しかし、オリゴヌクレオチド合成市場は、品質管理の確保、規制基準の遵守、遺伝子合成に関する倫理的懸念への対応といった課題に直面しています。さらに、オリゴヌクレオチド合成の複雑化、専門的な機器や専門知識の必要性は、市場参入企業にとって大きなハードルとなっています。このような課題にもかかわらず、市場は新たな合成技術の開発やオリゴヌクレオチドの応用分野の拡大など、技術革新の機会を提供しています。さらに、個別化医療や遺伝子治療に対する需要の高まりは、市場拡大の道を開く。全体として、オリゴヌクレオチド合成市場は継続的な成長の態勢を整えているが、コスト、技術熟練度、品質保証、規制遵守に関連する障害に遭遇する可能性があります。
目次
エグゼクティブサマリー
- 市場概要
- 運命の輪
調査手法
- 情報調達
- 二次データソースと一次データソース
- 市場規模の推定
- 市場の危機と限界
親市場の分析
- 市場概要
- 市場規模
- 市場力学
- 促進要因
- 機会
- 抑制要因
- 課題
主な市場の考察
- 技術分析
- 価格分析
- サプライチェーン分析
- バリューチェーン分析
- 市場のエコシステム
- IP分析
- 貿易分析
- スタートアップ分析
- 原材料の分析
- イノベーションマトリクス
- パイプライン製品の分析
- マクロ経済指標
- 主な投資の分析
- 主な成功要因
- 競合の程度
市場力学と見通し
- 市場力学
- 促進要因
- 機会
- 抑制要因
- 課題
- 規制情勢
- ポーターの分析
- 将来の混乱についての特別な考察
オリゴヌクレオチド合成の世界市場：最終用途別
- 市場概要
- 学術研究機関
- 診断検査室
- 製薬バイオテクノロジー企業
オリゴヌクレオチド合成の世界市場：用途別
- 市場概要
- PCRプライマー
- PCRアッセイとパネル
- シーケンシング
- DNAマイクロアレイ
- 蛍光in situハイブリダイゼーション（FISH）
- アンチセンスオリゴヌクレオチド
- その他のアプリケーション
オリゴヌクレオチド合成の世界市場規模：地域別
- 市場概要
- 北米
- 米国
- カナダ
- 欧州
- ドイツ
- スペイン
- フランス
- 英国
- その他の欧州
- アジア太平洋
- 中国
- インド
- 日本
- 韓国
- その他のアジア太平洋
- ラテンアメリカ
- ブラジル
- その他のラテンアメリカ
- 中東・アフリカ（MEA）
- GCC諸国
- 南アフリカ
- その他の中東・アフリカ
競合情勢
- 上位5社の比較
- 主要企業の市場ポジショニング（2021年）
- 主な市場企業が採用した戦略
- 主要成功戦略
- 市場における最近の活動
- 主要企業の市場シェア（2021年）
主要企業プロファイル
- Agilent Technologies, Inc.（US）
- BioAutomation Corporation（US）
- Biosearch Technologies, Inc.（US）
- Biolytic Lab Performance Inc.（Canada）
- Eurofins Genomics LLC（US）
- General Electric Company（US）
- GenScript Biotech Corporation（China）
- Integrated DNA Technologies, Inc.（US）
- Kaneka Eurogentec S.A.（Belgium）
- LGC Limited（UK）
- Merck KGaA（Germany）
- Nitto Denko Avecia Inc.（US）
- Thermo Fisher Scientific Inc.（US）
- TriLink BioTechnologies, LLC（US）
- Twist Bioscience Corporation（US）
- ATDBio Ltd.（UK）
- Axil Scientific Pte Ltd.（Singapore）
- Biogen International GmbH（Switzerland）
- Biomer Technology LLC（US）
- Bio-Synthesis, Inc.（US）
Global oligonucleotide synthesis market size was valued at USD 4.60 billion in 2022 and is poised to grow from USD 5.16 billion in 2023 to USD 12.86 billion by 2031, at a CAGR of 12.10% during the forecast period (2024-2031).
The oligonucleotide synthesis market serves the needs of researchers, scientists, and manufacturers by offering customized and pre-manufactured oligonucleotides for various purposes, including gene synthesis, PCR, DNA sequencing, diagnostics, and therapeutics. A primary driver of this market is the rising demand for synthetic biology and personalized medicine, fueled by advancements in genetic research. Additionally, the growing incidence of cancer and genetic disorders contributes to the market's growth. However, the oligonucleotide synthesis market encounters challenges such as ensuring quality control, adhering to regulatory standards, and addressing ethical concerns related to gene synthesis. Moreover, the increasing complexity of oligonucleotide synthesis and the requirement for specialized equipment and expertise present significant hurdles for market participants. Despite these challenges, the market offers opportunities for innovation, including the development of new synthesis technologies and expanding the application areas for oligonucleotides. Furthermore, the rising demand for personalized medicine and gene therapy creates avenues for market expansion. Overall, while the oligonucleotide synthesis market is poised for continued growth, it may encounter obstacles related to cost, technical proficiency, quality assurance, and regulatory compliance.
Top-down and bottom-up approaches were used to estimate and validate the size of the global oligonucleotide synthesis market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.
Global Oligonucleotide Synthesis Market Segmental Analysis
The global oligonucleotide synthesis market is segmented based on end-use, application, and region. By end-use, the market is segmented into academic research institutes, diagnostic laboratories, and pharmaceutical - biotechnology companies. By application, the market is segmented into PCR primers, PCR assays and panels, sequencing, DNA microarrays, fluorescence in situ hybridization (FISH), Antisense oligonucleotides, and other applications. By region, the market is segmented into North America, Europe, Asia Pacific, Middle East and Africa, and Latin America.
Drivers of the Global Oligonucleotide Synthesis Market
The global oligonucleotide synthesis market is being propelled by the increasing need for oligonucleotides in drug development and diagnostics. Oligonucleotides such as PCR primers, antisense oligonucleotides, and siRNA are extensively utilized in these fields, contributing to the market's growth.
Restraints in the Global Oligonucleotide Synthesis Market
The oligonucleotide synthesis market faces a notable hurdle due to the high cost associated with the synthesis process. This complexity necessitates specialized equipment and expertise, thereby increasing the manufacturing expenses for oligonucleotides.
Market Trends of the Global Oligonucleotide Synthesis Market
The demand for tailored oligonucleotides has been on the rise, catering to specific applications in fields like research, diagnostics, and therapeutics. This trend is driven by the expanding utilization of oligonucleotides in drug development, genetic testing, and personalized medicine. Integrated DNA Technologies, a prominent supplier of customized oligonucleotides, exemplifies this trend by offering a diverse array of oligonucleotides tailored for various research, diagnostic, and therapeutic purposes.
Table of Contents
Executive Summary
- Market Overview
- Wheel of Fortune
Research Methodology
- Information Procurement
- Secondary & Primary Data Sources
- Market Size Estimation
- Market Assumptions & Limitations
Parent Market Analysis
- Market Overview
- Market Size
- Market Dynamics
- Drivers
- Opportunities
- Restraints
- Challenges
Key Market Insights
- Technology Analysis
- Pricing Analysis
- Supply Chain Analysis
- Value Chain Analysis
- Ecosystem of the Market
- IP Analysis
- Trade Analysis
- Startup Analysis
- Raw Material Analysis
- Innovation Matrix
- Pipeline Product Analysis
- Macroeconomic Indicators
- Top Investment Analysis
- Key Success Factor
- Degree of Competition
Market Dynamics & Outlook
- Market Dynamics
- Drivers
- Opportunities
- Restraints
- Challenges
- Regulatory Landscape
- Porters Analysis
- Competitive rivalry
- Threat of Substitute Products
- Bargaining Power of Buyers
- Threat of New Entrants
- Bargaining Power of Suppliers
- Skyquest Special Insights on Future Disruptions
- Political Impact
- Economic Impact
- Social Impact
- Technical Impact
- Environmental Impact
- Legal Impact
Global Oligonucleotide Synthesis Market by End-use
- Market Overview
- Academic Research Institutes
- Diagnostic Laboratories
- Pharmaceutical Biotechnology Companies
Global Oligonucleotide Synthesis Market by Application
- Market Overview
- PCR Primers
- PCR Assays and Panels
- Sequencing
- DNA Microarrays
- Fluorescence in Situ Hybridization (FISH)
- Antisense Oligonucleotides
- and Other Applications
Global Oligonucleotide Synthesis Market Size by Region
- Market Overview
- North America
- USA
- Canada
- Europe
- Germany
- Spain
- France
- UK
- Rest of Europe
- Asia Pacific
- China
- India
- Japan
- South Korea
- Rest of Asia-Pacific
- Latin America
- Brazil
- Rest of Latin America
- Middle East & Africa (MEA)
- GCC Countries
- South Africa
- Rest of MEA
Competitive Landscape
- Top 5 Player Comparison
- Market Positioning of Key Players, 2021
- Strategies Adopted by Key Market Players
- Top Winning Strategies
- By Development
- By Company
- By Year
- Recent Activities in the Market
- Key Companies Market Share (%), 2021
Key Company Profiles
- Agilent Technologies, Inc. (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- BioAutomation Corporation (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Biosearch Technologies, Inc. (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Biolytic Lab Performance Inc. (Canada)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Eurofins Genomics LLC (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- General Electric Company (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- GenScript Biotech Corporation (China)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Integrated DNA Technologies, Inc. (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Kaneka Eurogentec S.A. (Belgium)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- LGC Limited (UK)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Merck KGaA (Germany)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Nitto Denko Avecia Inc. (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Thermo Fisher Scientific Inc. (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- TriLink BioTechnologies, LLC (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Twist Bioscience Corporation (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- ATDBio Ltd. (UK)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Axil Scientific Pte Ltd. (Singapore)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Biogen International GmbH (Switzerland)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Biomer Technology LLC (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Bio-Synthesis, Inc. (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
